Diagnostic Performance of the BioFire® Joint Infection Panel in Native Septic Arthritis and Periprosthetic Joint Infection: A Retrospective Diagnostic Accuracy Study

ArticleAçık Erişim

Özet

Objective: Rapid identification of causative microorganisms is essential in suspected native septic arthritis and periprosthetic joint infection. This study evaluated the diagnostic performance of the BioFire® Joint Infection Panel and assessed its agreement with conventional culture and systemic inflammatory biomarkers. Methods: Hospital records from January 2025 to April 2026 were retrospectively reviewed. Of 115 screened patients with suspected joint infection, nine were excluded because BioFire® testing had not been performed and only culture results were available. The final analysis included 106 synovial fluid samples. All samples were tested using conventional culture and the BioFire® Joint Infection Panel during the same clinical episode. Demographic data, infection category, localization, C-reactive protein, erythrocyte sedimentation rate, procalcitonin, and white blood cell count were recorded. Agreement was assessed using Cohen’s kappa, discordance using the McNemar test, and diagnostic performance using culture as the reference method. Results: Sixty-five samples (61.3%) were classified as suspected native septic arthritis and 41 (38.7%) as periprosthetic joint infection. BioFire® was positive in 22 samples (20.8%) and culture was positive in 32 (30.2%). Overall agreement was 86.8%, with substantial agreement according to Cohen’s kappa (0.656). Discordance was significant, predominantly due to culture-positive/BioFire®-negative samples (P = 0.013). BioFire® showed 62.5% sensitivity [95% confidence interval (CI): 43.7-78.9), 97.3% specificity (95% CI: 90.6-99.7), 90.9% positive predictive value, 85.7% negative predictive value, and 86.8% accuracy. C-reactive protein, procalcitonin, and white blood cell counts were significantly higher in patients with suspected native septic arthritis. Conclusion: The BioFire® Joint Infection Panel provides rapid and highly specific microbiological support in suspected joint infection. However, its moderate sensitivity and inability to detect off-panel organisms indicate that it should complement rather than replace conventional culture.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/17137Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.4274/abcr.2026.26448Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorGÜR, VOLKAN
dc.contributor.authorAKYÜZ, Sümeyye
dc.contributor.authorYapici, Furkan
dc.contributor.authorGülhan, Barış
dc.contributor.authorDOĞAN, İBRAHİM
dc.contributor.authorGökgöz, Mehmet Burak
dc.contributor.authorOzturk, Akin
dc.contributor.authorTopaluğurlu, Nedim Batuhan
dc.contributor.authorDündar, Harun
dc.date.accessioned2026-10-18T20:49:20.722989890Z
dc.date.available2026-10-18T20:49:20.722989890Z
dc.date.issued2026
dc.description.abstractObjective: Rapid identification of causative microorganisms is essential in suspected native septic arthritis and periprosthetic joint infection. This study evaluated the diagnostic performance of the BioFire® Joint Infection Panel and assessed its agreement with conventional culture and systemic inflammatory biomarkers. Methods: Hospital records from January 2025 to April 2026 were retrospectively reviewed. Of 115 screened patients with suspected joint infection, nine were excluded because BioFire® testing had not been performed and only culture results were available. The final analysis included 106 synovial fluid samples. All samples were tested using conventional culture and the BioFire® Joint Infection Panel during the same clinical episode. Demographic data, infection category, localization, C-reactive protein, erythrocyte sedimentation rate, procalcitonin, and white blood cell count were recorded. Agreement was assessed using Cohen’s kappa, discordance using the McNemar test, and diagnostic performance using culture as the reference method. Results: Sixty-five samples (61.3%) were classified as suspected native septic arthritis and 41 (38.7%) as periprosthetic joint infection. BioFire® was positive in 22 samples (20.8%) and culture was positive in 32 (30.2%). Overall agreement was 86.8%, with substantial agreement according to Cohen’s kappa (0.656). Discordance was significant, predominantly due to culture-positive/BioFire®-negative samples (P = 0.013). BioFire® showed 62.5% sensitivity [95% confidence interval (CI): 43.7-78.9), 97.3% specificity (95% CI: 90.6-99.7), 90.9% positive predictive value, 85.7% negative predictive value, and 86.8% accuracy. C-reactive protein, procalcitonin, and white blood cell counts were significantly higher in patients with suspected native septic arthritis. Conclusion: The BioFire® Joint Infection Panel provides rapid and highly specific microbiological support in suspected joint infection. However, its moderate sensitivity and inability to detect off-panel organisms indicate that it should complement rather than replace conventional culture.
dc.identifier.doi10.4274/abcr.2026.26448
dc.identifier.eissn2687-4482
dc.identifier.endpage200
dc.identifier.issn2687-4520
dc.identifier.issue2
dc.identifier.startpage194
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/17137
dc.identifier.volume8
dc.language.isoen
dc.relation.ispartofArchives of Basic and Clinical Research
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectMikrobiyoloji
dc.subjectEnfeksiyon Hastalıkları
dc.subjectOrtopedi
dc.titleDiagnostic Performance of the BioFire® Joint Infection Panel in Native Septic Arthritis and Periprosthetic Joint Infection: A Retrospective Diagnostic Accuracy Study
dc.typeArticle
dspace.entity.typePublication
rdl.citation.trdizin0
rdl.departmentERZİNCAN BİNALİ YILDIRIM ÜNİVERSİTESİ
rdl.source.indexTRDIZIN